Compound Summary
Compound Information
procainamide hydrochloride
Compound Name: | procainamide hydrochloride |
Compound CID: | 66068 |
Synonyms: | procainamide hydrochloride Procainamide Hcl 614-39-1 Pronestyl Procanbid More... |
Iupac Name: | 4-amino-N-[2-(diethylamino)ethyl]benzamide;hydrochloride |
InChI: | InChI=1S/C13H21N3O.ClH/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11;/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17);1H |
InChIKey: | ABTXGJFUQRCPNH-UHFFFAOYSA-N |
Canonical Smiles: | CCN(CC)CCNC(=O)C1=CC=C(C=C1)N.Cl |
Isomeric Smiles: | CCN(CC)CCNC(=O)C1=CC=C(C=C1)N.Cl |
Molecular Weight: | 271.78 |
Molecular Formula: | C13H22ClN3O |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
procainamide hydrochloride
Molecular Weight: | 271.78 |
Molecular Formula: | C13H22ClN3O |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 6 |
Heavy Atom Count: | 18 |
Complexity: | 221 |
Synonyms
procainamide hydrochloride
| procainamide hydrochloride | procainamide hydrochloride |
|---|---|
procainamide hydrochloride |
Procainamide Hcl |
614-39-1 |
Pronestyl |
Procanbid |
Procapan |
Procan |
4-amino-N-2-(diethylamino)ethylbenzamide hydrochloride |
Procainamide (hydrochloride) |
Pronestyl-Sr |
Benzamide, 4-amino-N-2-(diethylamino)ethyl-, monohydrochloride |
UNII-SI4064O0LX |
4-Amino-N-(2-diethylaminoethyl)benzamide hydrochloride |
4-amino-N-2-(diethylamino)ethylbenzamide;hydrochloride |
MFCD00012998 |
MLS000069436 |
CHEBI:8429 |
SI4064O0LX |
SMR000059079 |
Benzamide, 4-amino-N-(2-(diethylamino)ethyl)-, monohydrochloride |
Procainhydrochlorid |
Procan SR |
Procainii chloridum |
Promide hydrochloride |
Procapan hydrochloride |
Novocamid hydrochloride |
Procaini hydrochloridum |
Procamide hydrochloride |
Procardyl hydrochloride |
4-Amino-N-(2-(diethylamino)ethyl)benzamide hydrochloride |
Procan-SR hydrochloride |
Procaine amide hydrochloride |
Supicane amide hydrochloride |
PROCAINAMIDEHYDROCHLORIDE |
CCRIS 7143 |
SR-01000000022 |
CAS-614-39-1 |
EINECS 210-381-7 |
C13H22ClN3O |
(4-aminophenyl)-N-2-(diethylamino)ethylcarboxamide, chloride |
Benzamide, 4-amino-N-(2-(diethylamino)ethyl)-, hydrochloride (1:1) |
Benzamide, 4-amino-N-2-(diethylamino)ethyl-, hydrochloride (1:1) |
Procanbid (TN) |
Pronestyl (TN) |
Procainamide hydrochloride USP:JAN |
Procan SR (TN) |
4-Aminobenzoesaeure-2-diethylaminoethylester hydrochlorid |
7699-39-0 |
p-Amino-N-(2-(diethylamino)ethyl)benzamide hydrochloride |
Pronestyl hydrochloride |
4-Amino-N-(2-(diethylamino)ethyl)benzamide monohydrochloride |
p-Amino-N-(2-(diethylamino)ethyl)benzamide monohydrochloride |
Opera_ID_1543 |
Procainamide, hydrochloride |
CHEMBL605 |
Epitope ID:140114 |
DSSTox_CID_29382 |
DSSTox_RID_83497 |
DSSTox_GSID_49422 |
SCHEMBL40758 |
MLS001148635 |
SPECTRUM1500503 |
DTXSID2049422 |
Benzamide, p-amino-N-(2-(diethylamino)ethyl)-, hydrochloride |
HMS1569C15 |
HMS1920L04 |
Pharmakon1600-01500503 |
ACT08464 |
AMY22225 |
BCP28404 |
HY-A0084 |
Tox21_202855 |
Tox21_500995 |
CCG-39233 |
NSC757279 |
s4294 |
SBB001067 |
AKOS008056264 |
AC-7552 |
EBD3071181 |
KS-5258 |
LP00995 |
MCULE-9726613752 |
NC00535 |
NSC 757279 |
NSC-757279 |
Procainamide hydrochloride (JP17/USP) |
VA11587 |
NCGC00094291-01 |
NCGC00094291-02 |
NCGC00094291-03 |
NCGC00094291-04 |
NCGC00094291-05 |
NCGC00260401-01 |
NCGC00261680-01 |
M850 |
DB-053889 |
Procainamide hydrochloride, >=98% (HPLC) |
4-Aminobenzoic acid 2-diethylaminoethylamide |
EU-0100995 |
FT-0603493 |
ST50319808 |
SW196878-3 |
VU0239777-5 |
A14240 |
BIM-0050968.0001 |
D00477 |
D97622 |
P 9391 |
4-amino-N-(2-diethylamino-ethyl)-benzamide HCl |
Procainamide hydrochloride, purum, >=98.0% (AT) |
SR-01000000022-2 |
SR-01000000022-6 |
W-105155 |
Q27108080 |
F0850-6742 |
4-amino-N-2-(diethylamino)ethyl-Benzamide hydrochloride |
Procainamide hydrochloride, European Pharmacopoeia (EP) Reference Standard |
Procainamide hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material |
Procainamide hydrochloride, United States Pharmacopeia (USP) Reference Standard |
Experimental Data
procainamide hydrochloride
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | 3 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
procainamide hydrochloride
Statistics Data
procainamide hydrochloride
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 3 | 1 | 1 |
Statistics Data Visualization
procainamide hydrochloride
